Accounting for global protein deformability during protein-protein and protein-ligand docking.

[1]  Martin Zacharias,et al.  Refinement of protein cores and protein-peptide interfaces using a potential scaling approach. , 2005, Protein engineering, design & selection : PEDS.

[2]  M. Sternberg,et al.  The relationship between the flexibility of proteins and their conformational states on forming protein-protein complexes with an application to protein-protein docking. , 2005, Journal of molecular biology.

[3]  C. Prigent,et al.  The Protein Kinase Resource: everything you always wanted to know about protein kinases but were afraid to ask , 2005, Biology of the cell.

[4]  Haruki Nakamura,et al.  A hybrid method of molecular dynamics and harmonic dynamics for docking of flexible ligand to flexible receptor , 2004, J. Comput. Chem..

[5]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[6]  M. Noble,et al.  The role of structure in kinase-targeted inhibitor design. , 2004, Current opinion in drug discovery & development.

[7]  Claudio N. Cavasotto,et al.  Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.

[8]  Susan S. Taylor,et al.  PKA: a portrait of protein kinase dynamics. , 2004, Biochimica et biophysica acta.

[9]  Martin Zacharias,et al.  Rapid protein–ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: Binding of FK506 to FKBP , 2004, Proteins.

[10]  Richard Lavery,et al.  Docking macromolecules with flexible segments , 2003, J. Comput. Chem..

[11]  J Andrew McCammon,et al.  Protein flexibility and computer-aided drug design. , 2003, Annual review of pharmacology and toxicology.

[12]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[13]  S. Teague.  Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[14]  Martin Zacharias,et al.  Protein–protein docking with a reduced protein model accounting for side‐chain flexibility , 2003, Protein science : a publication of the Protein Society.

[15]  E. Sausville,et al.  Issues and progress with protein kinase inhibitors for cancer treatment , 2003, Nature Reviews Drug Discovery.

[16]  Susan S. Taylor,et al.  Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme crystal structure. , 2003, Journal of molecular biology.

[17]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[18]  J. Mccammon,et al.  Computational drug design accommodating receptor flexibility: the relaxed complex scheme. , 2002, Journal of the American Chemical Society.

[19]  Jonathan W. Essex,et al.  A review of protein-small molecule docking methods , 2002, J. Comput. Aided Mol. Des..

[20]  D. Goodsell,et al.  Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.

[21]  I Kolossváry,et al.  Fully flexible low-mode docking: application to induced fit in HIV integrase. , 2001, Journal of the American Chemical Society.

[22]  R Abagyan,et al.  High-throughput docking for lead generation. , 2001, Current opinion in chemical biology.

[23]  Thomas Lengauer,et al.  FlexE: efficient molecular docking considering protein structure variations. , 2001, Journal of molecular biology.

[24]  Y. Sanejouand,et al.  Conformational change of proteins arising from normal mode calculations. , 2001, Protein engineering.

[25]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[26]  Gennady Verkhivker,et al.  Deciphering common failures in molecular docking of ligand-protein complexes , 2000, J. Comput. Aided Mol. Des..

[27]  Rafael Najmanovich,et al.  Side‐chain flexibility in proteins upon ligand binding , 2000, Proteins.

[28]  J A McCammon,et al.  Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.

[29]  Youngshang Pak,et al.  Application of a Molecular Dynamics Simulation Method with a Generalized Effective Potential to the Flexible Molecular Docking Problems , 2000 .

[30]  Christopher W. Murray,et al.  The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase , 1999, J. Comput. Aided Mol. Des..

[31]  J. Andrew McCammon,et al.  Method for Including the Dynamic Fluctuations of a Protein in Computer-Aided Drug Design , 1999 .

[32]  A. di Nola,et al.  Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation , 1999, Proteins.

[33]  A. Davis,et al.  Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis. , 1999, Angewandte Chemie.

[34]  Heinz Sklenar,et al.  Harmonic modes as variables to approximately account for receptor flexibility in ligand–receptor docking simulations: Application to DNA minor groove ligand complex , 1999 .

[35]  K. Hinsen.  Analysis of domain motions by approximate normal mode calculations , 1998, Proteins.

[36]  R Nussinov,et al.  Flexible docking allowing induced fit in proteins: Insights from an open to closed conformational isomers , 1998, Proteins.

[37]  Amedeo Caflisch,et al.  Docking small ligands in flexible binding sites , 1998, J. Comput. Chem..

[38]  Ruth Nussinov,et al.  A Method for Biomolecular Structural Recognition and Docking Allowing Conformational Flexibility , 1998, J. Comput. Biol..

[39]  R. Huber,et al.  Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential. , 1997, Structure.

[40]  A. Atilgan,et al.  Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. , 1997, Folding & design.

[41]  I. Kuntz,et al.  Molecular docking to ensembles of protein structures. , 1997, Journal of molecular biology.

[42]  J Deisenhofer,et al.  Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. , 1996, Journal of molecular biology.

[43]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[44]  G. Vriend,et al.  Molecular docking using surface complementarity , 1996, Proteins.

[45]  K. Schulten,et al.  Principal Component Analysis and Long Time Protein Dynamics , 1996 .

[46]  M. Murcko,et al.  Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. , 1995, Acta crystallographica. Section D, Biological crystallography.

[47]  A. Leach,et al.  Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.

[48]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[49]  Bostjan Kobe,et al.  Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats , 1993, Nature.

[50]  R F Standaert,et al.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.

[51]  M Karplus,et al.  Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin , 1991, Science.

[52]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.